ArticleJGH open : an open access journal of gastroenterology and hepatology2020

Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease.

Arne Carlsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.